Spirometry Interpretation Performance of Primary Care Clinicians With/Without AI Software

Last updated: February 15, 2024
Sponsor: Royal Brompton & Harefield NHS Foundation Trust
Overall Status: Active - Recruiting

Phase

N/A

Condition

Lung Disease

Treatment

ArtiQ.Spiro diagnostic and quality assessment report

Artificial Intelligence-powered Spirometry Interpretation Report

Clinical Study ID

NCT05933694
323361
  • Ages 18-99
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

To evaluate whether an artificial intelligence decision support software (ArtiQ.Spiro) improves the diagnostic accuracy of spirometry interpreted by primary care clinicians, as measured by Clinician Diagnostic Accuracy (vs Reference Standard).

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Clinicians working in primary care (for at least 50% of their job plan) in the UK, whorefer for or perform spirometry (typically GP, practice nurse)
  2. Able to access spirometry traces on study platform
  3. Provide written informed consent via study platform

Exclusion

Exclusion Criteria:

  1. Clinicians who have completed specialist training in respiratory medicine and recognisedby the General Medical Council with a right to practise as a NHS consultant in respiratorymedicine

Study Design

Total Participants: 228
Treatment Group(s): 2
Primary Treatment: ArtiQ.Spiro diagnostic and quality assessment report
Phase:
Study Start date:
June 27, 2023
Estimated Completion Date:
September 30, 2024

Study Description

This is a randomised controlled study to evaluate the effects of AI support software on the performance of primary care clinicians in the interpretation of spirometry. Clinicians will be provided with a clinical dataset of 50 entirely anonymous, previously recorded real-world spirometry records to interpret and will be asked to complete specific questions about diagnosis and quality assessment. The records will be randomly selected from a database comprising spirometry records from 1122 patients undergoing spirometry in primary care and community -based respiratory clinics in Hillingdon borough between 2015-2018.

Participating clinicians will be allocated at random to receive either spirometry records alone or spirometry records with the addition of an AI spirometry interpretation eport. The clinical spirometry records will be de-identified (name, date of birth, address, postcode, occupation, GP, medications data removed), by a member of the clinical care team.

Study participants (participating clinicians) will independently examine the same 50 spirometry records through an online platform. For each spirometry record, the primary care clinician participant will answer questions about technical quality, pattern interpretation, preferred diagnosis, differential diagnosis and self-rated confidence with these answers.

The study statistician will be blinded to treatment allocation up to completion of analysis and interpretation.

The reference standards for spirometry technical quality and pattern interpretation will be made by a senior experienced respiratory physiologist but without access to AI report.

The reference standard for diagnosis will be made by a panel of three respiratory specialists from the clinical care team with access to medical notes and results of relevant investigations but without access to AI report.

Connect with a study center

  • Royal Brompton & Harefield Hospitals

    Uxbridge, UB9 6JH
    United Kingdom

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.